Share >  
Share
Share on Tumblr

Plethico Pharmaceuticals

News »

   latest by relevance
CRISIL assigns valuation grade of 5/5 to Plethico Pharma
Aug 18, 2011 at 14:27 | Source: Moneycontrol.com
CRISIL Research has come out with its report on Plethico Pharmaceuticals. The research firm has assigned a valuation grade of 5/5 to the company and assigned fundamental grade of 3/5 in its August 17, 2011 report.
CRISIL assigns valuation grade of 5/5 to Plethico Pharma
Jun 03, 2011 at 15:29 | Source: Moneycontrol.com
CRISIL Research has come out with its report on Plethico Pharmaceuticals. The research firm has initiated coverage on the company with a Valuation Grade of 5/5 and has maintained the fair value of Rs 530 per share.
CRISIL assigns valuation grade of 5/5 to Plethico Pharma
May 17, 2011 at 13:00 | Source: Moneycontrol.com
CRISIL Research has come out with its report on Plethico Pharmaceuticals. The research firm has initiated coverage on Plethico Pharmaceuticals with a Valuation Grade of 5/5 and has maintained the fair value of Rs 530 per share.
Plethico Pharma Q4 cons PAT down 23% at Rs 55 cr
May 16, 2011 at 12:00 | Source: Moneycontrol.com
Plethico Pharma has announced its foruth quarter results. The company's Q4FY11 consolidated revenues were up 5.4% at Rs 354 crore versus Rs 336 crore.
CRISIL assigns valuation grade of 5/5 to Plethico Pharma
Apr 26, 2011 at 19:00 | Source: Moneycontrol.com
CRISIL Research has come out with its report on Plethico Pharmaceuticals. The research firm has initiated coverage on Plethico Pharmaceuticals with a Valuation Grade of 5/5 and maintain the fair value of Rs 530 per share.
Expect around 18-20% growth going forward: Plethico Pharma
Apr 01, 2011 at 16:47 | Source: CNBC-TV18
Sanjay Pai, CFO, Plethico Pharmaceuticals says, the company grew about 22% year-on-year. He further says, the company has been growing at a steady rate of 18-20%. He expects similar kind of growth going forward.

Videos »
Expect around 18-20% growth going forward: Plethico Pharma
Plethico Pharma plans to raise $60-100m for debt repayment
Plethico Pharma sees 15-18% growth in next 2 yrs
Stocks to watch: TCS, Plethico Pharma
Expect 30% upside in Plethico Pharma: A Maheshwari
more »

Photos »

  /  
News across the web »
RBI Declined Proposed FCCB Restructuring By Plethico: Sanjay Pai, CFO
BY SNEHA SHAH This has put a question mark over how the company plans to meet the redemption call. The Indian central bank has rejected a proposed restructuring of foreign currency convertible bonds (...
Apr 16, 2012 at 20:00 | Source: VC Circle
Plethico Pharma To Extend FCCB Repayment Deadline
BY SNEHA SHAH Healthcare and pharmaceutical manufacturer Plethico Pharmaceuticals Ltd has approached the Reserve Bank of India to extend the deadline for the repayment of outstanding foreign currency ...
Apr 10, 2012 at 20:00 | Source: VC Circle
more »
Interact & exchange stock tips & market info »

Market Statistician

Platinum Member

4331 Followers

Plethico Pharma  

Plethico Pharmaceuticals has touched a 52-week high of R...

2.15 PM May 10th

Market Statistician

Platinum Member

4331 Followers

Plethico Pharma  

Plethico Pharmaceuticals has touched a 52-week high of R...

12.15 PM May 10th

MMB Messenger

Platinum Member

112614 Followers

Plethico Pharma  

Plethico Pharmaceuticals Ltd has submitted the disclosur...

7.20 PM Apr 18th

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window